Showing results (51-60 of 579) with videos related to
Sort By:
Pageof 58
Aging|February 15, 2019
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs)Federica Sotgia, Marco Fiorillo, Michael P LisantiAging|October 29, 2017
A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesisBela Ozsvari, Federica Sotgia, Michael P LisantiCell Cycle (Georgetown, Tex.)|January 5, 2011
Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biologyChenguang Wang, Michael P Lisanti, D Joshua LiaoCancer Biology & Therapy|November 13, 2004
Caveolin-1 in breast cancerToula Bouras, Michael P Lisanti, Richard G PestellGiornale Italiano Di Cardiologia|November 1, 1983
[Mexiletine: electrophysiologic effects]A Rizzo, F Sisto, R Fiorilli, et al.Giornale Italiano Di Cardiologia|October 27, 1998
Single coronary artery: a case reportR Fiorilli, G Argento, P Lisanti, et al.Pharmacological Reviews|September 12, 2002
Caveolae: from cell biology to animal physiologyBabak Razani, Scott E Woodman, Michael P LisantiAging|December 24, 2022
SOX2-high cancer cells exhibit an aggressive phenotype, with increases in stemness, proliferation and invasion, as well as higher metabolic activity and ATP productionMarta Mauro-Lizcano, Federica Sotgia, Michael P LisantiSeminars in Oncology|May 3, 2014
Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and functionUbaldo Martinez-Outschoorn, Federica Sotgia, Michael P LisantiAging|June 4, 2024
Mitophagy and cancer: role of BNIP3/BNIP3L as energetic drivers of stemness features, ATP production, proliferation, and cell migrationMarta Mauro-Lizcano, Federica Sotgia, Michael P LisantiPageof 58